Zhang Kan, Cheng Dan, Yi Lingling, Shi Huimin, Zhen Guohua
Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, China ; Key Laboratory of Respiratory Diseases, National Health and Family Planning Commission of the People's Republic of China Wuhan, China.
Int J Clin Exp Pathol. 2014 Aug 15;7(9):6291-300. eCollection 2014.
Angiotensin I-converting enzyme (ACE) gene plays an important role in the pathogenesis of cancers. The association between ACE insertion/deletion (I/D) polymorphism and the risk of various cancers has been studied. However, the results of these studies remain conflicting. Therefore, we performed a meta-analysis to evaluate the association between ACE I/D polymorphism and the risk of cancers.
PubMed, Embase, ScienceDirect, Springer, CNKI, Wanfang, Weipu, CBM databases and Google Scholar were searched for case-control studies on ACE I/D polymorphism and the risk of cancers, published up to Dec 31, 2013. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of the association between ACE I/D polymorphism and cancer risk.
Thirty-five published studies with 5007 cases and 8173 controls were included. Overall, there were no significant association between ACE I/D polymorphism and the risk of cancers (II vs. ID+DD OR = 1.05, 95% CI = 0.89-1.23, I vs. D OR = 1.00, 95% CI = 0.89-1.13). However, when stratified by ethnicity, we found a significant association between this polymorphism and cancer risk in Caucasians (II vs. ID+DD: OR = 1.43, 95% CI = 1.02-2.00, I vs. D: OR = 1.23, 95% CI 1.01-1.49).
ACE I/D polymorphism is associated with the cancer risk in Caucasians.
血管紧张素I转换酶(ACE)基因在癌症发病机制中起重要作用。已对ACE插入/缺失(I/D)多态性与各种癌症风险之间的关联进行了研究。然而,这些研究结果仍存在冲突。因此,我们进行了一项荟萃分析,以评估ACE I/D多态性与癌症风险之间的关联。
检索了PubMed、Embase、ScienceDirect、Springer、中国知网、万方、维普、中国生物医学文献数据库以及谷歌学术,查找截至2013年12月31日发表的关于ACE I/D多态性与癌症风险的病例对照研究。采用比值比(OR)及95%置信区间(CI)评估ACE I/D多态性与癌症风险之间关联的强度。
纳入了35项已发表研究,共5007例病例和8173例对照。总体而言,ACE I/D多态性与癌症风险之间无显著关联(II vs. ID+DD:OR = 1.05,95% CI = 0.89 - 1.23;I vs. D:OR = 1.00,95% CI = 0.89 - 1.13)。然而,按种族分层时,我们发现该多态性与白种人的癌症风险之间存在显著关联(II vs. ID+DD:OR = 1.43,95% CI = 1.02 - 2.00;I vs. D:OR = 1.23,95% CI 1.01 - 1.49)。
ACE I/D多态性与白种人的癌症风险相关。